With the analysis among 422 patents, we discovered top 160 key players by total patent application. OSI Pharmaceuticals, Inc., Bristol Myers Squibb Co., Oncogene Science, Inc. are dominant in this area. They take 12.80% of the total patent filing.
New York, United States
Patent: 24
New York, United States
Patent: 15
New York, United States
Patent: 15
California, United States
Patent: 14
Massachusetts, United States
Patent: 13
Taiwan Province, China
Patent: 12
Vaud, Switzerland
Patent: 11
California, United States
Patent: 11
California, United States
Patent: 10
With the analysis among 15 patents, we discovered top 7 start-ups by total patent application. GeneMedicine, DRAGONFLY Therapeutics, Inc., Asana BioSciences LLC are active in this area.
Massachusetts, United States
Patent: 2
New Jersey, United States
Patent: 2
Massachusetts, United States
Patent: 2
Guangdong Sheng, China
Patent: 1
Cygnal Therapeutics, Inc.
Massachusetts, United States
Patent: 1
With the analysis among related 140 patents applied in the last 5 years. We discover 102 most active companies in this area. The fast-growing Guizhou University, Shandong Boan Biotechnology Co., Ltd., Soochow University take 20.71% of patent filing during this period.
Guizhou Sheng, China
Patent: 15
Shandong Sheng, China
Patent: 8
Jiangsu Sheng, China
Patent: 6
Shaanxi Sheng, China
Patent: 2
Hubei Sheng, China
Patent: 2
Nordrhein-Westfalen, Germany
Patent: 2
With the analysis among related 140 patents in last 5 years, we discover 81 new entrants. Shandong Boan Biotechnology Co., Ltd., Dalian Blue Peptide Technology Research & Development Co.Ltd, DRAGONFLY Therapeutics, Inc. are the most active new entrants in this area.
Shandong Sheng, China
Patent: 8
Liaoning Sheng, China
Patent: 2
Massachusetts, United States
Patent: 2
Nordrhein-Westfalen, Germany
Patent: 2
Shaanxi Sheng, China
Patent: 2
Hubei Sheng, China
Patent: 2
Nordrhein-Westfalen, Germany
Patent: 2
Jiangsu Sheng, China
Patent: 2
With the analysis among 227 patents, we discovered top 72 universities and scientific research institutions by total patent application. Guizhou University, Shanghai Institute of Materia Medica Chinese Academy of Sciences, Capital University of Medical Sciences are dominant in this area. They take 20.70% of the total patent filing.
Guizhou Sheng, China
Patent: 22
Shanghai Shi, China
Patent: 11
Beijing Shi, China
Patent: 8
Jiangsu Sheng, China
Patent: 8
California, United States
Patent: 6
Hubei Sheng, China
Patent: 5
Shanghai Shi, China
Patent: 5
North Carolina, United States
Patent: 3
Massachusetts, United States
Patent: 3
Guizhou Sheng, China
Patent: 3